AbbVie Delivers on Scorching Humira Drug Sales Growth

26.04.2013 - AbbVie reported slightly better than expected quarterly results on Friday, fueled by surging sales of its Humira treatment for rheumatoid arthritis. Sales of Humira, which accounts...